Menu Back toHow-Risk-Based-Monitoring-and-eSource-Methodologies-are-Impacting-Clinical-Sites-Patients-Regulators-and-Sponsors

DIA 2015 51st Annual Meeting: Develop. Innovate. Advance.

Full conference and one-day registrants will have access to presentation PDFs through Friday, December 18, 2015 <A href="">Review Presentations </A>

How Risk-Based Monitoring and eSource Methodologies Are Impacting Clinical Sites, Patients, Regulators and Sponsors

    Session Chair(s)
      Jules T Mitchel, PhD, MBA

      Jules T Mitchel, PhD, MBA

      • President
      • Target Health, Inc., United States
    This symposium will show how risk-based monitoring and eSource methodologies are impacting the way clinical trials are being conducted and managed.
    Learning Objective : Discuss results and experience from completed and ongoing clinical trials; Identify how eSource and risk-based monitoring methodologies are impacting the clinical research enterprise including clinical research sites, patients, regulators, quality assurance, clinical research associates (CRA), and project, safety and data managers.
      Frances  Nolan, MBA

      The Time Is Now for Risk-Based Monitoring

      Frances Nolan, MBA

      • Independent Consultant
      • Independent Consulting, United States
      Avik Kumar Pal, MBA

      Overcoming Clinical Trial Data Collection Challenges with eSource Solution and Leveraging Mobile Technologies

      Avik Kumar Pal, MBA

      • Chief Executive Officer
      • CliniOps, United States
      Edward Stephen Seguine, MBA

      Innovation by Design: Using eSource to Maximize Clinical Development Productivity and Efficiency

      Edward Stephen Seguine, MBA

      • Chief Executive Officer
      • Clinical Ink, United States

Contact us

DIA Americas
800 Enterprise Road, Suite 200
Horsham, PA 19044-3595, USA
Phone: +1 215 442 6100
Fax: +1 215 442 6199

Questions related to the DIA 2015 51st Annual Meeting Program? Contact:

Ways to register

Registration override should work.